CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$0.52
-0.07 (-12.54%)
Open$0.61
Previous Close$0.59
Day High$0.62
Day Low$0.52
52W High$4.98
52W Low$0.50
Volume—
Avg Volume32.0K
Market Cap9.51M
P/E Ratio—
EPS$-1.02
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,231.4% upside
Current
$0.52
$0.52
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 711.8K | 2.22M | 1.91M |
| Net Income | -22,934,570 | -64,402,848 | 134.3K |
| Profit Margin | -3,225.1% | -3,063.8% | 7.0% |
| EBITDA | -22,411,029 | -66,428,947 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | -68.0% | -68.0% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |